AbbVie: Muscle Spasticity trials

The registry lists 19 Muscle Spasticity studies with AbbVie as lead sponsor. 0 are open to participants now and 12 have results posted.

Phase 1 1Phase 2 3Phase 3 7Phase 4 1No phase 7(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• OnabotulinumtoxinA Treatment in Adult Patients With Upper Limb SpasticityTerminatedNCT02145676Phase 3Results posted
• Safety and Efficacy of BOTOX® (Botulinum Toxin Type A) in KoreaCompletedNCT02043145Results posted
• BOTOX® Open-Label Treatment in Pediatric Lower Limb SpasticityCompletedNCT01603641Phase 3Results posted
• BOTOX® Treatment in Pediatric Lower Limb SpasticityCompletedNCT01603628Phase 3Results posted
• BOTOX® Open-Label Treatment in Pediatric Upper Limb SpasticityCompletedNCT01603615Phase 3Results posted
• BOTOX® Treatment in Pediatric Upper Limb SpasticityCompletedNCT01603602Phase 3Results posted
• BOTOX® Treatment in Adult Patients With Post-Stroke Lower Limb SpasticityCompletedNCT01575054Phase 3Results posted
• Observational Study of Botox® Treatment for Patients With Upper Limb Adult SpasticityCompletedNCT01387074Results posted
• Retrospective Study of Patients With Spasticity in the Spanish PopulationCompletedNCT01383681Results posted
• BOTOX® Economic Spasticity Trial (BEST)CompletedNCT00549783Phase 4Results posted
• MDs on Botox Utility (MOBILITY)CompletedNCT00535938Results posted
• Safety Study of Botulinum Toxin Type A in Post-Upper Limb Stroke Patients With Reduced Lung FunctionCompletedNCT00076687Phase 2Results posted
• Study of Intramuscular Injections of OnabotulinumtoxinA to Assess Change in Disease Activity in Pediatric Participants With Spasticity Associated With Cerebral PalsyCompletedNCT06150729
• Study of Intramuscular Injections of ABBV-950 to Assess Adverse Events and Change in Disease Activity in Adult Participants With Upper Limb SpasticityTerminatedNCT05956509Phase 1
• Long-Term Study of OnabotulinumtoxinA Treatment in Adult Patients With Upper Limb SpasticityWithdrawnNCT02145689Phase 3
• Spasticity Registry Evaluating Epidemiology, Treatment Patterns and Clinical NeedsWithdrawnNCT02145650
• An Adult Spasticity Registry of OnabotulinumtoxinA TreatmentCompletedNCT01930786
• Safety Study of Botulinum Toxin Type A for the Treatment of Focal Upper Limb Poststroke SpasticityCompletedNCT00651729Phase 2
• Study of Responsiveness of Seven Functional Tasks in Patients With Poststroke Upper Limb Spasticity With Botulinum Toxin Type A TreatmentCompletedNCT00651690Phase 2